Crown Castle Inc <CCI.N>: Truist Securities cuts target price to $87 from $95
CCI•Related News
Lantern Pharma To Advance EMA-Cleared Phase 1B/2 Trial Of Lp-184 (Zirdafulven) In Biomarker-Selected Advanced Bladder Cancer
LTRN•
NCR Atleos expands collaboration with Credit Union 1 via Circle K ATM branding deal in Alaska
NATL•
Turn Therapeutics releases corporate deck outlining GX-03 topical immunomodulator program for atopic dermatitis
TTRX•
Fastly management to present at KeyBanc Technology Leadership Forum
FSLY•
Clearmind Medicine Successfully Completes Part A Of Its FDA Regulated Phase I/Ii Trial
CMND•